
Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo
How to Cite
OrthoEvidence. Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo. ACE Report. 2018;7(9):22. Available from: https://myorthoevidene.com/AceReport/Report/10376
Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
65 patients with chronic abdominal pain following surgery or due to chronic pancreatitis were randomized to receive delta-9-tetrahydrocannabinol (THC) or placebo for 50-52 days. The primary outcome was pain relief, as measured by a visual analogue scale (VAS). Secondary outcomes included other measures of pain, depression, anxiety, quality of life, treatment satisfaction, appetite, alertness, mood...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE